RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Montelukast

Prophylaxis and chronic treatment of asthma, Acute prevention of exercise-induced bronchoconstriction (EIB), Relief of symptoms of seasonal allergic rhinitis, Relief of symptoms of perennial allergic rhinitis

Boxed warning

  • WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS Serious neuropsychiatric (NP) events have been reported with the use of montelukast sodium. The types of events reported were highly variable, and included, but were not limitedto, agitation, aggression, depression, sleep disturbances, suicidal thoughts and behavior (including suicide). The mechanisms underlying NP events associated with montelukast sodium use are currently not well understood [see Warnings and Precautions (5.1) ] . Because of the risk of NP events, the ... (see full label)

Indications

  • Prophylaxis and chronic treatment of asthma
  • Acute prevention of exercise-induced bronchoconstriction (EIB)
  • Relief of symptoms of seasonal allergic rhinitis
  • Relief of symptoms of perennial allergic rhinitis

Adult dosing

  • asthma: dose: 10; unit: mg; route: PO; interval: once daily in the evening; fixed: true; labelExcerpt: 15 years and older: one 10 mg tablet ( 2 )
  • eib: dose: 10; unit: mg; route: PO; interval: at least 2 hours before exercise; fixed: true; labelExcerpt: 15 years and older: one 10 mg tablet ( 2 )
  • allergic rhinitis: dose: 10; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: 15 years and older: one 10 mg tablet ( 2 )

Pediatric dosing

  • asthma 6 to 14: dose: 5; unit: mg; route: PO; interval: once daily in the evening; fixed: true; labelExcerpt: 6 to 14 years: one 5 mg chewable tablet ( 2 )
  • asthma 2 to 5: dose: 4; unit: mg; route: PO; interval: once daily in the evening; fixed: true; labelExcerpt: 2 to 5 years: one 4 mg chewable tablet ( 2 )

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Hypersensitivity to any component

Clinical pearls

  • Not indicated for the treatment of acute asthma attacks.
  • Monitor for neuropsychiatric symptoms; discontinue if they occur.
  • Patients with aspirin sensitivity should avoid NSAIDs while taking montelukast.
  • 4 mg and 5 mg chewable tablets contain phenylalanine; advise patients with phenylketonuria.

Source and review

  • DailyMed label (montelukast sodium), Set ID 6ffff72c-8784-477b-8722-5434a19881a0, effective 2026-10-27. Last reviewed: 2026-11-11